LOX-1 in atherosclerotic disease.
Matsumoto, Japan. In Clin Chim Acta, Mar 2015
We hypothesized that LOX-1 is a candidate risk factor beyond LDL cholesterol (LDLC) and developed a novel assay to quantify LOX-1 ligand containing apoB (LAB).
Lipoproteins, stroke and statins.
Genova, Italy. In Curr Vasc Pharmacol, 2014
In this review, we want to point out the role of the different lipoproteins, such as triglycerides, HDL-C, LDLC, Lp(a), in the pathogenesis of stroke and the role of statins in reducing both lipid fractions and stroke risk.
Haematological and serum biochemical responses of chickens to hydric stress.
Durban, South Africa. In Animal, 2013
Packed cell volume (PCV), erythrocyte count (RBC), mean corpuscular volume (MCV) and total leucocyte count (WBC), and biochemical parameters (uric acid (UA)), creatinine (CREAT), total protein (TP), albumin (ALB), globulin (GLOB), triglyceride (TGA), total cholesterol (TC), high- (HDLC) and low- (LDLC) density lipoprotein cholesterol and activity of alanine transaminase (ALT), alkaline phosphatase (ALP) and aspartate transaminase (AST) were determined from blood collected after 60 days of water restriction.
Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs).
Newcastle upon Tyne, United Kingdom. In Clin Res Hepatol Gastroenterol, 2013
Several host factors associated with response to pegylated interferon-α and ribavirin are not as important in predicting response to triple therapy, and yet low-density lipoprotein cholesterol (LDLC) and statin use remain important associations of outcome with DAAs.